An original bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2020, and for other purposes.
Legislative Progress
Introduced
September 12, 2019
Latest Action
September 12, 2019
Primary Sponsor
Richard C. ShelbyRepublican(AL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Department of Defense Appropriations Act, 2020 This bill provides FY2020 appropriations to the Department of Defense (DOD) for military activities. The bill excludes military construction, military family housing, civil works projects of the Army Corps of Engineers, and nuclear warheads, which are all considered in other appropriations bills. Within the DOD budget, the bill provides appropriations for Military Personnel; Operation and Maintenance; Procurement; Research, Development, Test and Evaluation; and Revolving and Management Funds. The bill provides appropriations for Other Department of Defense Programs, including the Defense Health Program, Chemical Agents and Munitions Destruction, Drug Interdiction and Counter-Drug Activities, and the Office of the Inspector General. The bill also provides appropriations for (1) Related Agencies, including the Central Intelligence Agency Retirement and Disability System Fund and the Intelligence Community Management Account; and (2) Overseas Contingency Operations. The bill sets forth restrictions and requirements for using funds provided by this and other appropriations Acts.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (149)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 205.
Committee on Appropriations. Original measure reported to Senate by Senator Shelby. With written report No. 116-103.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2024 · fourth_quarter · Health Issues
H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 3633, PREVENT HPV Cancers Act of 2023 H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7635, The 340B PATIENTS Act of 2024 H.R. 8467, Farm, Food, and National Security Act of 2024 S. 150, Affordable Prescriptions for Patients Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 S. 4229, Reducing Drug Prices for Seniors Act. Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; Issues related to the Patent and Trademark Law Amendments Act (PL 96-517); FY-2024 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; National Institute of Standards and Technology (NIST) draft Interagency Guidance Framework for Considering the Exercise of March-In Rights Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues.
Client expense: $1,800,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · fourth_quarter · Health Issues
H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 3633, PREVENT HPV Cancers Act of 2023 H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7635, The 340B PATIENTS Act of 2024 H.R. 8467, Farm, Food, and National Security Act of 2024 S. 150, Affordable Prescriptions for Patients Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 S. 4229, Reducing Drug Prices for Seniors Act. Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; Issues related to the Patent and Trademark Law Amendments Act (PL 96-517); FY-2024 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; National Institute of Standards and Technology (NIST) draft Interagency Guidance Framework for Considering the Exercise of March-In Rights Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues.
2024 · third_quarter · Health Issues
H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 3633, PREVENT HPV Cancers Act of 2023 H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7635, The 340B PATIENTS Act of 2024 H.R. 8467, Farm, Food, and National Security Act of 2024 S. 150, Affordable Prescriptions for Patients Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 S. 4229, Reducing Drug Prices for Seniors Act. Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; Issues related to the Patent and Trademark Law Amendments Act (PL 96-517); FY-2024 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; National Institute of Standards and Technology (NIST) draft Interagency Guidance Framework for Considering the Exercise of March-In Rights Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues.
2024 · second_quarter · Health Issues
H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 3633, PREVENT HPV Cancers Act of 2023 H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7635, The 340B PATIENTS Act of 2024 H.R. 8467, Farm, Food, and National Security Act of 2024 S. 150, Affordable Prescriptions for Patients Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 S. 4229, Reducing Drug Prices for Seniors Act. Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; Issues related to the Patent and Trademark Law Amendments Act (PL 96-517); FY-2024 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; National Institute of Standards and Technology (NIST) draft Interagency Guidance Framework for Considering the Exercise of March-In Rights Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues.
2024 · first_quarter · Health Issues
H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 3633, PREVENT HPV Cancers Act of 2023 H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7635, The 340B PATIENTS Act of 2024 S. 150, Affordable Prescriptions for Patients Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; Issues related to the Patent and Trademark Law Amendments Act (PL 96-517); FY-2024 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Farm Bill 2023; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms.
Client expense: $1,730,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $2,190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $3,010,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $2,190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 1550, (117th Cong.) PREVENT HPV Cancers Act of 2021 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act S. 150, Affordable Prescriptions for Patients Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; Issues related to the Patent and Trademark Law Amendments Act (PL 96-517); FY-2023 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Farm Bill 2023; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms.
Client expense: $1,940,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1418/S. 1844, Animal Drug User Fee Amendments of 2023 H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 1550, (117th Cong.) PREVENT HPV Cancers Act of 2021 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act S. 150, Affordable Prescriptions for Patients Act of 2023 S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 4348, (117th Cong) Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Anti-microbial Resistance; Vaccines; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; FY-2023 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; Animal Drug User Fee Reauthorization; One Health Issues; General pharmaceutical issues; Farm Bill 2023; Vaccine Injury Compensation Program (VICP); Step therapy requirements in commercial health plans; Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues Pharmacy Benefit Manager reforms.
Client expense: $2,130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Defense
S 1970 / HJR 2500 - National Defense Authorization Act for Fiscal Year 2020, S 2474 / HR 2968 - Department of Defense Appropriations Act, 2020, Technology and artificial intelligence
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · fourth_quarter · Tariff (miscellaneous tariff bills)
Steel trade, imports and exports, and manufacturing, Section 232 of PL 87-794, Section 301 of PL 93-618, and NAFTA PL 103-182. S. 2474, FY 2020 Department of Defense Appropriations bill.
Client expense: Not reported · Firm income: $50,000
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
2020 · fourth_quarter · Defense
Issues related to technology; Issues related to government contracting; Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Budget/Appropriations
Issues relating to Department of Defense operations, including records management, in the National Defense Authorization Act (S.1790) and FY 2020 Department of Defense Appropriations (H.R. 2968/S. 2474); Issues related to H.R. 925 - The Heroes Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
HR 2968; S 2474 Department of Defense Appropriations Act 2021,Tuberous Sclerosis Complex Research program HR 1158, Consolidated Appropriations Act, Tuberous Sclerosis Complex Research Program HR 7614/S no bill number, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2021, NIH Research HR 1865, Further Consolidated Appropriations Act, NIH research Peer-Reviewed Medical Research Program
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · third_quarter · Defense
S 1970 / HJR 2500 - National Defense Authorization Act for Fiscal Year 2020, S 2474 / HR 2968 - Department of Defense Appropriations Act, 2020, Technology and artificial intelligence
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · third_quarter · Tariff (miscellaneous tariff bills)
Steel trade, imports and exports, and manufacturing,Section 232 of PL 87-794,Section 301 of PL 93-618, and NAFTA PL 103-182. S. 2474, FY 2020 Department of Defense Appropriations bill.
Client expense: Not reported · Firm income: $50,000
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
2020 · third_quarter · Health Issues
HR 2968; S 2474 Department of Defense Appropriations Act 2021,Tuberous Sclerosis Complex Research program HR 1158, Consolidated Appropriations Act, Tuberous Sclerosis Complex Research Program HR 7614/S no bill number, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2021, NIH Research HR 1865, Further Consolidated Appropriations Act, NIH research Peer-Reviewed Medical Research Program
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Defense
Issues related to technology; Issues related to government contracting; Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Budget/Appropriations
Issues relating to Department of Defense operations, including records management, in the National Defense Authorization Act (S.1790) and FY 2020 Department of Defense Appropriations (H.R. 2968/S. 2474); Issues related to H.R. 925 - The Heroes Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Defense
H.R.2968, Department of Defense Appropriations Act, 2020 S.2474, Department of Defense Appropriations Act, 2020 S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R., 6395, National Defense Authorization Act for Fiscal Year 2021
Client expense: $240,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2020 · first_quarter · Budget/Appropriations
H.R. 1865, FY2020 Further Consolidated Appropriations Act (Labor, Health and Human Services, Education, Agriculture, Energy Water, Interior, Leg. Branch, Military Construction and Veterans Affairs, State-For. Ops, Transportation, Housing, and Urban Development), bills for FY 20 appropriations for the National Institute of Health. H.R. 1865, H.R.3052 and S. 2580, FY2020, Further Consolidated Appropriations Act (Labor, Health and Human Services, Education, Agriculture, Energy Water, Interior, Leg. Branch, Military Construction and Veterans Affairs, State-For. Ops, Transportation, Housing, and Urban Development). These bills provide FY2020 appropriations for the Department of the Interior, the Environmental Protection Agency (EPA), and related agencies. H.R. 1158, H.R. 2968, S. 2474, FY2020 Consolidated Appropriations Act (Defense, Commerce, Justice, Science, Financial Services and General Government, Homeland Security). These bills provide FY2020 appropriations for the Department of Defense. H.R.2500 and S.1790, National Defense Authorization Act for Fiscal Year 2020. These bills authorize FY2020 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, including military personnel strengths.
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Homeland Security
H.R. 2, Investing in a New Vision for the Environment and Surface Transportation in America (INVEST) in America Act H.R. 251, Chemical Facility Anti-Terrorism Standards Program Extension Act H.R. 748/S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1668/S. 734, IoT Cybersecurity Improvement Act of 2019 H.R. 1731/S. 592, Cybersecurity Disclosure Act of 2019 H.R. 2968/S. 2474, Department of Defense Appropriations Act, 2020, including provisions relating to operational cybersecurity H.R. 3256, Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019 H.R. 4217, State and Local Cybersecurity Improvement Act H.R. 4482, Protecting America's Food and Agriculture Act of 2019 H.R. 4978, Online Privacy Act of 2019 H.R. 4998, Secure and Trusted Communications Networks Act of 2019 H.R. 5273, Securing America's Ports Act H.R. 5680/S. 3045, Cybersecurity Vulnerability Identification and Notification Act of 2019 H.R. 5823, State and Local Cybersecurity Improvement Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7331, National Cyber Director Act S. 893, Secure 5G and Beyond Act of 2019 S. 1625, United States 5G Leadership Act of 2019 S. 1846, State and Local Government Cybersecurity Act of 2019 S. 2664, Cyber Shield Act of 2019 S. 2775, Harvesting American Cybersecurity Knowledge through Education (HACKED) Act of 2019 S. 3045, Cybersecurity Vulnerability Identification and Notification Act of 2019 S. 3712, Cybersecurity Competitions to Yield Better Efforts to Research the Latest Exceptionally Advanced Problems (Cyber Leap) Act of 2020 S. 3928, Continuity of the Economy Act of 2020 S. 3929, National Guard Cyber Interoperability Act Draft legislation on motor vehicles including cybersecurity Draft legislation on cybersecurity tax credit Draft legislation titled Cyber Collaborative Operations (Cyber Co-op) Act Draft legislation titled United States Consumer Data Privacy Act of 2019 Draft legislation titled Cyber SAFETY Act Proposed rule regarding remote identification of unmanned aircraft systems (84 Fed. Reg. 72,438-72,524, December 31, 2019) Various issues relating to Chemical Facility Anti-Terrorism Standards (CFATS) program reauthorization; implementation of the John S. McCain National Defense Authorization Act for Fiscal Year 2019, including sections 889(a)(1)(A) and (a)(1)(B) and Title XVII, Foreign Investment Risk Review Modernization Act (P.L. 115-232), including provisions relating to sections 1654 and 1655; deepening business and governmental operational collaboration against foreign cyber threats; National Institute of Standards and Technology (NIST) Framework for Improving Critical Infrastructure Security; small and midsize business cybersecurity assistance; 5G; cybersecurity protections; cyber workforce, including cybersecurity professionals securing business and government networks; cyber incident reporting of breaches, hacks, and other security incidents; Internet of Things (IoT) security; Office of the Director of National Intelligence (ODNI)s cyber customer services; Bureau of Industry and Security final rule, addition of entities to the entity list; Bureau of Industry and Security, temporary general license, extension of validity; Bureau of Industry and Security, future extension of temporary general license (TGL); Commerce, Justice, Science appropriations; cyberspace solarium commission report and recommendations; coronavirus and COVID-19 issues including critical workforce; Department of Commerce proposed rule securing the information and communications technology and services supply chain; Department of Defense Cybersecurity Maturity Model Certification (CMMC) v.1.0; Department of Homeland Security report on combating trafficking in counterfeit and pirated goods; Department of Defense, General Services Administration, and NASA interim rule, Federal Acquisition Regulation: Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment; Executive Order 13904 ensuring safe & lawful e-commerce for US consumers, businesses, government supply chains, and intellectual property rights; Federal Trade Commission (FTC), Fair and Accurate Credit Transactions Act of 2003 (P.L. 108-159), regulatory flexibility National Institute of Standards and Technology (NIST) NISTIR 8259, recommendations for IoT device Manufacturers: Foundational Activities and Core Device Cybersecurity Capability Baseline (2nd Draft); inquiries to various federal agencies on supply chain disruptions due to COVID-19; National Defense Authorization Act for Fiscal Year 2019 and related regulations (P.L. 115-232); National Defense Authorization Act for Fiscal Year 2020 (P.L. 116-92); National Security Council (NSC), U.S. international standards engagement; National Telecommunications and Information Administration (NTIA), software component transparency; legislation related to section 889 of the National Defense Authorization Act for Fiscal Year 2019 (P.L. 115-232); proposed rulemakings on Modernization of the Customs Brokers Regulations and Elimination of Customs Broker District Permit Fee; Fiscal Year 2021 Transportation, Housing and Urban Development, and Related Agencies Appropriations; Executive Order 13920, Securing the United States Bulk-Power System; Defense Production Act of 1950 (P.L. 81-774); security clearance reform legislation; potential privacy legislation, including data security; issues related to coronavirus; Department of Homeland Security (DHS) Cybersecurity and Infrastructure Security Agencys (CISA) recent Guidance on the Essential Critical Infrastructure Workforce: Ensuring Community and National Resilience in COVID-19 Response; procurement issues; issues related to China
Client expense: $12,300,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Labor Statistics (BLS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2020 · second_quarter · Budget/Appropriations
Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020; Issues regarding H.R. 2470 - Clean Water Infrastructure Resilience and Sustainability Act; Issues related to H.R. 2 and funding for University Transportation Centers; Issues related to FY 2021 Defense Appropriations; Issues related to funding for university research and UARCs.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · second_quarter · Budget/Appropriations
Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020; Issues regarding H.R. 2470 - Clean Water Infrastructure Resilience and Sustainability Act; Issues related to H.R. 2 and funding for University Transportation Centers; Issues related to FY 2021 Defense Appropriations; Issues related to funding for university research and UARCs.
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · second_quarter · Budget/Appropriations
FY20 appropriations for transportation, FAA, DOD and Justice. Transportation, Housing and Urban Development Appropriations Act/S. 2520 Defense Appropriations Act/S. 2474 CJS Appropriations Act/S. 2584 LHHS and Education Appropriations Act HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act HR 6201 - Families First Coronavirus Response Act HR 748 - CARES Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Tariff (miscellaneous tariff bills)
Steel trade, imports and exports, and manufacturing,Section 232 of PL 87-794,Section 301 of PL 93-618, and NAFTA PL 103-182. S. 2474, FY 2020 Department of Defense Appropriations bill.
Client expense: Not reported · Firm income: $50,000
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), White House Office
2020 · second_quarter · Defense
H.R.2968, Department of Defense Appropriations Act, 2020 S.2474, Department of Defense Appropriations Act, 2020 S. 4049, National Defense Authorization Act for Fiscal Year 2021 H.R., 6395, National Defense Authorization Act for Fiscal Year 2021
Client expense: $240,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2020 · second_quarter · Budget/Appropriations
Issues regarding H.R 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
Issues related to the opioid crisis; Issues related to NIH funding; Issues related to wound care; Issues related to FY 2020 Appropriations and Defense funding, including H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020 & H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Defense
Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Budget/Appropriations
Issues related to FY 2020 Appropriations, including H.R. 3055/S. 2584 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 and H.R 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Defense
Issues related to technology; Issues related to government contracting; Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Budget/Appropriations
Issues relating to Department of Defense operations, including records management, in the National Defense Authorization Act (S.1790) and FY 2020 Department of Defense Appropriations (H.R. 2968/S. 2474).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Tariff (miscellaneous tariff bills)
Steel trade, imports and exports, and manufacturing,Section 232 of PL 87-794,Section 301 of PL 93-618, and NAFTA PL 103-182. S. 2474, FY 2020 Department of Defense Appropriations bill.
Client expense: Not reported · Firm income: $50,000
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), White House Office
2020 · second_quarter · Health Issues
HR 2968; S 2474 Department of Defense Appropriations Act 2020,Tuberous Sclerosis Complex Research program HR 1158, Consolidated Appropriations Act, Tuberous Sclerosis Complex Research Program HR 7614/S no bill number, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020, NIH Research HR 1865, Further Consolidated Appropriations Act, NIH research Peer-Reviewed Medical Research Program
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · second_quarter · Health Issues
Research opportunities at the Department of Defense and the Centers for Disease Control HR 2968; S 2474, Department of Defense Appropriations Act 2020, research on vascular malformations HR 1158, Consolidated Appropriations Act, DoD research on vascular malformations HR 7614/S. no bill number, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020, NIH research on HHT HR 1865, Further Consolidated Appropriations Act, NIH research on HHT
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · first_quarter · Budget/Appropriations
FY20 appropriations for transportation, FAA, DOD and Justice. Transportation, Housing and Urban Development Appropriations Act/S. 2520 Defense Appropriations Act/S. 2474 CJS Appropriations Act/S. 2584 LHHS and Education Appropriations Act HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act HR 6201 - Families First Coronavirus Response Act HR 748 - CARES Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Budget/Appropriations
H.R. 21: Consolidated Appropriations Act, 2019 - FDA provisions related to prescription drugs H.R. 265: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019 - FDA provisions related to prescription drugs House H.R. 648: Consolidated Appropriations Act, 2019 - FDA provisions related to prescription drugs H.R. 748: CARES Act - Provisions related to Part B, Part D, vaccines, transparency, and transportation H.R. 1158: Consolidated Appropriations Act, 2020 - Provisions related to prescription drugs, Medicare funding, and other provisions H.R. 1865: Consolidated Appropriations Act, 2020 - Provisions related to prescription drugs, Medicare funding, and other provisions H.R. 2401: American Cures Act - Provisions related to biomedical research funding H.R. 2500: National Defense Authorization Act for Fiscal Year 2020 - DoD provisions related to prescription drugs H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 - HHS provisions related to prescription drugs H.R. 2745: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020 - VA provisions related to prescription drugs H.R. 2968: Department of Defense Appropriations Act, 2020 - DoD provisions related to prescription drugs H.R. 3055: Making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2020, and for other purposes - FDA provisions related to prescription drugs H.R. 3164: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 - FDA provisions related to prescription drugs H.R. 4378: Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 - Provisions related to Medicare funding H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 - Provisions related to biomedical research and prescription drug pricing provisions related to vaccine reimbursement H.R. 6201: Families First Coronavirus Response Act - Provisions related to Medicare funding H.R. 6373: To increase the amount available under the Defense Production Act of 1950 to respond to the coronavirus epidemic, and for other purposes - Provisions related to the Defense Production Act and medical devices H.R. 6379: Take Responsibility for Workers and Families Act - Provisions related to supplemental appropriations and federal health programs H. Res. 28: Providing for consideration of the bill (H.R. 264) making appropriations for financial services and general government for the fiscal year ending September 30, 2019, and for other purposes; providing for consideration of the bill (H.R. 265) making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes; providing for consideration of the bill (H.R. 266) making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; providing for consideration of the bill (H.R. 267) making appropriations for the Department of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; and waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules. H. Res. 293: Providing for budget enforcement for fiscal year 2020 H. Res. 436: Providing for further consideration of the bill (H.R. 2740) making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes H. Res. 4455: Providing for consideration of the bill (H.R. 3055) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2020, and for other purposes; relating to consideration of the bill (H.R. 2740) making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes; and providing for proceedings during the period from June 28, 2019, through July 8, 2019 S. 1215: National Defense Authorization Act for Fiscal Year 2020 - DoD provisions related to prescription drugs S. 1250: American Cures Act - Provisions related to biomedical research funding S. 2474: Department of Defense Appropriations Act, 2020 - DoD provisions related to prescription drugs S. 2522: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 - FDA provisions related to prescription drugs S. 3161: National Biomedical Research Act - Provisions related to federal biomedical research funding S. 3370: Coronavirus Vaccine Act - Provisions related to NIH funding S. 3548: CARES Act - Provisions related to supplemental appropriations and federal health programs S. ___: Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes
Client expense: $940,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2020 · first_quarter · Budget/Appropriations
H.R. 21: Consolidated Appropriations Act, 2019 - FDA provisions related to prescription drugs H.R. 265: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019 - FDA provisions related to prescription drugs H.R. 648: Consolidated Appropriations Act, 2019 - FDA provisions related to prescription drugs H.R. 748: CARES Act - Provisions related to Part B, Part D, vaccines, transparency, and transportation H.R. 1158: Consolidated Appropriations Act, 2020 - Provisions related to prescription drugs, Medicare funding, and other provisions H.R. 1865: Consolidated Appropriations Act, 2020 - Provisions related to prescription drugs, Medicare funding, and other provisions H.R. 2401: American Cures Act - Provisions related to biomedical research funding H.R. 2500: National Defense Authorization Act for Fiscal Year 2020 - DoD provisions related to prescription drugs H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 - HHS provisions related to prescription drugs H.R. 2745: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020 - VA provisions related to prescription drugs H.R. 2922: Respond NOW Act - Provisions related to funding to address opioid crisis H.R. 2968: Department of Defense Appropriations Act, 2020 - DoD provisions related to prescription drugs H.R. 3055: Making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2020, and for other purposes - FDA provisions related to prescription drugs H.R. 3164: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 - FDA provisions related to prescription drugs H.R. 4378: Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 - Provisions related to Medicare funding H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 - Provisions related to biomedical research and prescription drug pricing H.R. 6201: Families First Coronavirus Response Act - Provisions related to Medicare funding H.R. 6373: To increase the amount available under the Defense Production Act of 1950 to respond to the coronavirus epidemic, and for other purposes - Provisions related to the Defense Production Act and medical devices H.R. 6379: Take Responsibility for Workers and Families Act - Provisions related to supplemental appropriations and federal health programs H. Res. 28: Providing for consideration of the bill (H.R. 264) making appropriations for financial services and general government for the fiscal year ending September 30, 2019, and for other purposes; providing for consideration of the bill (H.R. 265) making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes; providing for consideration of the bill (H.R. 266) making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; providing for consideration of the bill (H.R. 267) making appropriations for the Department of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; and waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules. H. Res. 293: Providing for budget enforcement for fiscal year 2020 H. Res. 436: Providing for further consideration of the bill (H.R. 2740) making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes H. Res. 4455: Providing for consideration of the bill (H.R. 3055) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2020, and for other purposes; relating to consideration of the bill (H.R. 2740) making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes; and providing for proceedings during the period from June 28, 2019, through July 8, 2019 S. 1215: National Defense Authorization Act for Fiscal Year 2020 - DoD provisions related to prescription drugs S. 1250: American Cures Act - Provisions related to biomedical research funding S. 2474: Department of Defense Appropriations Act, 2020 - DoD provisions related to prescription drugs S. 2522: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 - FDA provisions related to prescription drugs S. 3161: National Biomedical Research Act - Provisions related to federal biomedical research funding S. 3370: Coronavirus Vaccine Act - Provisions related to NIH funding S. 3548: CARES Act - Provisions related to supplemental appropriations and federal health programs S. ___: Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes
Client expense: $9,020,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2020 · first_quarter · Budget/Appropriations
Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020; Issues regarding H.R. 2470 - Clean Water Infrastructure Resilience and Sustainability Act; H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 (Pub. L. 116-123), H.R. 6201 - Families First Coronavirus Response Act (Pub.L. 116-127), H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 (Pub.L. 116-136), issues regarding higher education, research, and academic medical centers.
Client expense: $170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Budget/Appropriations
H.R. 1865, FY2020 Further Consolidated Appropriations Act (Labor, Health and Human Services, Education, Agriculture, Energy Water, Interior, Leg. Branch, Military Construction and Veterans Affairs, State-For. Ops, Transportation, Housing, and Urban Development), bills for FY 20 appropriations for the National Institute of Health. H.R. 1865, H.R.3052 and S. 2580, FY2020, Further Consolidated Appropriations Act (Labor, Health and Human Services, Education, Agriculture, Energy Water, Interior, Leg. Branch, Military Construction and Veterans Affairs, State-For. Ops, Transportation, Housing, and Urban Development). These bills provide FY2020 appropriations for the Department of the Interior, the Environmental Protection Agency (EPA), and related agencies. H.R. 1158, H.R. 2968, S. 2474, FY2020 Consolidated Appropriations Act (Defense, Commerce, Justice, Science, Financial Services and General Government, Homeland Security). These bills provide FY2020 appropriations for the Department of Defense. H.R.2500 and S.1790, National Defense Authorization Act for Fiscal Year 2020. These bills authorize FY2020 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, including military personnel strengths.
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Budget/Appropriations
Issues regarding H.R 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Defense
H.R.2968, Department of Defense Appropriations Act, 2020 S.2474, Department of Defense Appropriations Act, 2020
Client expense: $240,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · first_quarter · Homeland Security
H.R. 251, Chemical Facility Anti-Terrorism Standards Program Extension Act H.R. 748/S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1668/S. 734, IoT Cybersecurity Improvement Act of 2019 H.R. 1731/S. 592, Cybersecurity Disclosure Act of 2019 H.R. 2968/S. 2474, Department of Defense Appropriations Act, 2020, including provisions relating to operational cybersecurity H.R. 3256, Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019 H.R. 4482, Protecting America's Food and Agriculture Act of 2019 H.R. 4978, Online Privacy Act of 2019 H.R. 4998, Secure and Trusted Communications Networks Act of 2019 H.R. 5273, Securing America's Ports Act H.R. 5680/S. 3045, Cybersecurity Vulnerability Identification and Notification Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act S. 893, Secure 5G and Beyond Act of 2019 S. 1625, United States 5G Leadership Act of 2019 S. 2664, Cyber Shield Act of 2019 S. 2775, Harvesting American Cybersecurity Knowledge through Education (HACKED) Act of 2019 Draft legislation on motor vehicles including cybersecurity Draft legislation titled Cyber Collaborative Operations (Cyber Co-op) Act Draft legislation titled United States Consumer Data Privacy Act of 2019 Draft legislation titled Cybersecurity Leap Act of 2020 Draft legislation titled Cyber SAFETY Act Proposed rule regarding remote identification of unmanned aircraft systems (84 Fed. Reg. 72,438-72,524, December 31, 2019) Various issues relating to Chemical Facility Anti-Terrorism Standards (CFATS) program reauthorization; implementation of the John S. McCain National Defense Authorization Act for Fiscal Year 2019, Title XVII, Foreign Investment Risk Review Modernization Act (P.L. 115-232), including provisions relating to sections 1654 and 1655; deepening business and governmental operational collaboration against foreign cyber threats; National Institute of Standards and Technology (NIST) Framework for Improving Critical Infrastructure cybersecurity; small and midsize business cybersecurity assistance; 5G; cybersecurity protections; cyber workforce, including cybersecurity professionals securing business and government networks; apprenticeships; cyber incident reporting of breaches, hacks, and other security incidents; Internet of Things (IoT) security; core capability baselines; Office of the Director of National Intelligence (ODNI)s cyber customer services; Bureau of Industry and Security final rule, addition of entities to the entity list; Bureau of Industry and Security final rule, temporary general license, extension of validity; Bureau of Industry and Security request for comments on future extensions of temporary general licenses (TGL); Cybersecurity Infrastructure Security Administration critical infrastructure during COVID-19; cyberspace solarium commission report; coronavirus and COVID-19 issues including critical workforce; Department of Commerce proposed rule securing the information and communications technology and services supply chain; Department of Defense Cybersecurity Maturity Model Certification (CMMC) v.1.0; Department of Homeland Security report on combating trafficking in counterfeit and pirated goods; Department of Defense, General Services Administration, and NASA interim rule, Federal Acquisition Regulation: Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment; Executive Order 13904 ensuring safe & lawful e-commerce for US consumers, businesses, government supply chains, and intellectual property rights; Federal Trade Commission (FTC), Fair and Accurate Credit Transactions Act of 2003 (P.L. 108-159), regulatory flexibility National Institute of Standards and Technology (NIST) NISTIR 8259, recommendations for IoT device Manufacturers: Foundational Activities and Core Device Cybersecurity Capability Baseline (2nd Draft); inquiries to various federal agencies on supply chain disruptions due to COVID-19; National Defense Authorization Act for Fiscal Year 2019 and related regulations (P.L. 115-232); National Defense Authorization Act for Fiscal Year 2020 (P.L. 116-92); FY2021 National Defense Authorization Act; National Security Council (NSC), U.S. international standards engagement; National Telecommunications and Information Administration (NTIA), software component transparency; Defense Production Act of 1950 (P.L. 81-774); security clearance reform legislation; potential privacy legislation, including data security; issues related to coronavirus; Department of Homeland Security (DHS) Cybersecurity and Infrastructure Security Agencys (CISA) recent Guidance on the Essential Critical Infrastructure Workforce: Ensuring Community and National Resilience in COVID-19 Response
Client expense: $15,770,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Labor Statistics (BLS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2020 · first_quarter · Budget/Appropriations
H.R. ____ / S.____ Department of Homeland Security Appropriations Bill, 2021 - Title III, all provisions related to enterprise geospatial services. H.R. ____ / S.____ Department of Defense Appropriations bill, 2021 - any title, all provisions related to enterprise geospatial services and intelligence analysis. Title II, all provisions related to geospatial services on military installations. Title IV, all provisions related to artificial intelligence analytical tools. H.R.2968 / S.2474, Department of Defense Appropriations Act, 2020 - Title IV, all provisions related to intelligence analysis. H.R. ____ / S.____ Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations bill, 2021 - Title I, all provisions related to National Road Network. H.R.3163 / S.2520, Departments of Transportation, Housing and Urban Development, and Related Agencies Appropriations bill, 2020 - Title I, all provisions related to National Road Network. H.R. ____ / S.____ Department of Agriculture Appropriations bill, 2021 - Title I, all provisions related to precision agriculture. H.R. ____ / S.____ Legislative Branch Appropriations bill, 2021 - Title I, all provisions related to geospatial tools. H.R.748, CARES Act - Division B, all provisions related to geospatial infrastructure within the Department of Homeland Security.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE
2020 · first_quarter · Defense
S. 1790/H.R. 2500 - National Defense Authorization Act for Fiscal Year 2020 - Defense Commissary Agency/alcohol sales S. 2474/H.R. 2968 - Department of Defense Appropriations Act, 2020 - Defense Commissary Agency/alcohol sales Department of Defense Appropriations Act, 2021 - Defense Commissary Agency/alcohol sales
Client expense: $1,290,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · first_quarter · Health Issues
Issues related to the opioid crisis; Issues related to NIH funding; Issues related to wound care; Issues related to FY 2020 Appropriations and Defense funding, including H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020 & H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Defense
Issues related to funding the metals affordability initiative; NDAA FY20 - H.R. 2500, S. 1215, Defense Approps FY20 - H.R. 2968, S. 2474; FY21 NDAA; FY21 Defense Appropriations
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Defense
H.R. 6157, FY19 Defense and Labor-HHS-Education Appropriations Minibus with Continuing Resolution, and H.J. Res 31, Making further continuing appropriations; FY 2021 Department of Defense Appropriations, FY2021 Department of State Appropriations. S. 2474, FY 2020 Department of Defense Appropriations bill. S. 2583, FY2021 Department of State Appropriations bill. Software, FY 2020 Department of Defense Appropriations, FY 2020 Department of Homeland Security Appropriations, FY 2020 State Department Appropriations, P.L. 116-93, P.L. 116-94
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
2020 · first_quarter · Tariff (miscellaneous tariff bills)
Steel trade, imports and exports, and manufacturing,Section 232 of PL 87-794,Section 301 of PL 93-618, and NAFTA PL 103-182. S. 2474, FY 2020 Department of Defense Appropriations bill.
Client expense: Not reported · Firm income: $50,000
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Defense
Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Budget/Appropriations
Issues related to H.R. 2968/S. 2474 - Department of Defense Appropriations Act, 2020; Issues regarding H.R. 2470 - Clean Water Infrastructure Resilience and Sustainability Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE